Oxidative Stress and Vascular Disease pp 155-181 | Cite as
Atherosclerosis, Oxidative Stress, and Endothelial Function
Abstract
Atherosclerosis and its associated vascular complications remain a major source of morbidity and mortality in western civilizations. In the United States alone, 5.8 million patients are discharged from the hospital annually with a diagnosis of cardiovascular disease (CVD) and in 1995 CVD claimed over 960,000 lives (1). This represents approximately 41% of all deaths in the United States and places cardiovascular disease as the number one cause of death in the United States, causing more deaths, in fact, than all types of cancer combined (1). In terms of economic costs, cardiovascular disease consumes approximately 20 billion dollars annually in direct health care costs and over 250 billion dollars annually if one includes lost productivity (1). Data from the World Health Organization indicate that continued global economic prosperity is likely to lead to an epidemic of CVD as developing countries acquire Western habits such as increased consumption of meat and tobacco (1). Thus, atherosclerosis is a major public health problem that consumes an enormous amount of resources.
Keywords
Nitric Oxide Endothelial Function Tyrosyl Radical Lipid Peroxyl Radical Vascular SuperoxidePreview
Unable to display preview. Download preview PDF.
References
- 1.American Heart Association. 1998 Heart and stroke statistical update. Internet. 1998. American Heart Association.Google Scholar
- 2.Stary HC, Chandler AB, Glagov S, Guyton JR, Insull WJ, Rosenfeld ME, Schaffer SA, Schwartz CJ, Wagner WD, Wissler RW. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation. 1994;89:2462.PubMedCrossRefGoogle Scholar
- 3.Libby P. Molecular basis of the acute coronary syndromes. Circulation. 1995;91:2844.PubMedCrossRefGoogle Scholar
- 4.Keaney JF, Jr., Vita JA. Atherosclerosis, oxidative stress, and antioxidant protection in endothelium-derived relaxing factor action. Prog Card Dis. 1995;38:129.CrossRefGoogle Scholar
- 5.Levine GN, Keaney JF, Jr., Vita JA. Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms. N Engl J Med. 1995;332:512.PubMedCrossRefGoogle Scholar
- 6.Radomski MW, Palmer RM, Moncada S. Comparative pharmacology of endotheliumderived relaxing factor, nitric oxide and prostacyclin in platelets. Br J Pharmacol. 1987;92:181.PubMedCrossRefGoogle Scholar
- 7.Ursini F, Maiorino M, Brigilius-Flohe R, Aumann KD, Roberi A, Schomburg D, Flohe L. Diversity of glutathione peroxidases. Methods Enzymol. 1995;252:38.PubMedCrossRefGoogle Scholar
- 8.Avissar N, Whitin JC, Annen PZ, Palmer IS, Cohen HJ. Antihuman plasma glutathione peroxidase antibodies: immunologic investigations to determine p;asma glutathione peroxidase protein and selenium content in plasma. Blood. 1989;73:318.PubMedGoogle Scholar
- 9.Loskutoff DJ, Edgington DS. Synthesis of a fibrinolytic activator and inhibitor by endothelial cells. Proc Natl Acad Sci USA. 1977;74:3903.PubMedCrossRefGoogle Scholar
- 10.Quyyumi AA, Dakak N, Andrews NP, Husain S, Arora S, Gilligan DM, Panza JA, Cannon RO, III. Nitric oxide activity in the human coronary circulation. J Clin Invest. 1995;95:1747.PubMedCrossRefGoogle Scholar
- 11.Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cGMP inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest. 1989;83:1774.PubMedCrossRefGoogle Scholar
- 12.Kubes P, Kurose I, Granger DN. NO donors prevent integrin-induced leukocyte adhesion but not P-selectin-dependent rolling in postischemic venules. Am. J. Physiol. 1994;267:H931.PubMedGoogle Scholar
- 13.Azuma H, Ishikawa M, Sekizaki S. Endothelium-dependent inhibition of platelet aggregation. Br J Pharmacol. 1986;88:411.PubMedCrossRefGoogle Scholar
- 14.Radomski MW, Palmer RM, Moncada S: Characterization of the L-arginine:nitric oxide pathway in human platelets. Br J Pharmacol. 1990; 101:325.PubMedCrossRefGoogle Scholar
- 15.Freedman JE, Loscalzo J, Barnard MR, Alpert C, Keaney JF, Jr., Michelson AD: Nitric oxide released from activated platelets inhibits platelet recruitment. J Clin Invest. 1997; 100:350.PubMedCrossRefGoogle Scholar
- 16.Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, Fishman MC. Hypertension in mice lacking the gene for endothelial nitric oxide syntase. Nature. 1995;377:239.PubMedCrossRefGoogle Scholar
- 17.Shesely EG, Maeda N, Kim HS, Desai KM, Krege JH, Laubach VE, Sherman PA, Sessa WC, Smithies O. Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc Natl Acad Sci USA. 1996;93:13176.PubMedCrossRefGoogle Scholar
- 18.Rudic RD, Shesely EG, Maeda N, Smithies O, Segal SS, Sessa WC. Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. J Clin Invest. 1998;101:731.PubMedCrossRefGoogle Scholar
- 19.Freedman, JE, Sauter, R, Ault KA, Huang PL, and Loscalzo J. Deficient platelet-derived nitric oxide and enhanced hemostasis in mice lacking the NOS3 gene. Circulation 1998;98:1–4.CrossRefGoogle Scholar
- 20.Freedman JE, Loscalzo J, Benoit SE, Valeri CR, Barnard MR, Michelson AD. Decreased platelet inhibition by nitric oxide in two brothers with a history of arterial thrombosis. J Clin Invest. 1996;97:979.PubMedCrossRefGoogle Scholar
- 21.Arnold WP, Mittal CK, Katsuki S, Murad F. Nitric oxide activates guanylate cyclase and increases guanosine 3’,5’-cyclic monophosphate levels in various tissue preparations. Proc Natl Acad Sci USA. 1977;74:3203.PubMedCrossRefGoogle Scholar
- 22.Ignarro LJ, Burke TM, Wood KS, Wolin MS, Kadowitz PJ. Association between cyclic GMP accumulation and acetylcholine-elicited relaxation of bovine intrapulmonary artery. J Pharmacol Exp Ther. 1984;228:682.PubMedGoogle Scholar
- 23.Moro MA, Russell RJ, Cellek S, Lizasoain I, Su Y, Darley-Usmar VM, Radomski MW, Moncada S. cGMP mediates the vascular and platelet actions of nitric oxide: Confirmation using an inhibitor of the soluble guanylyl cyclase. Proc Natl Acad Sci USA. 1995;93:1480.CrossRefGoogle Scholar
- 24.Radomski MW, Palmer RMJ, Moncada S. The role of nitric oxide and cGMP in platelet adhesion to the vascular endothelium. Biochem Biophys Res Commun. 1987;148:1482.PubMedCrossRefGoogle Scholar
- 25.Wink DA, Darbyshire JF, Nims RW, Saavedra JE, Ford PC. Reactions of the bioregulatory agent nitric oxide in oxygenated aqueous media: determination of the kinetics for oxidation and nitrosation by intermediates generated in the NO/O2 reaction. Chem Res Toxicol. 1993;6:23.PubMedCrossRefGoogle Scholar
- 26.Stamler JS, Singel DJ, Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms. Science. 1992;258:1898.PubMedCrossRefGoogle Scholar
- 27.Bolotina VM, Najibi S, Palacino JJ, Pagano PJ, Cohen RA. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature. 1994;368:850.PubMedCrossRefGoogle Scholar
- 28.Xu L, Eu JP, Meissner G, Stamler JS. Activation of the cardiac calcium release channel (ryonadine receptor by poly-S-nitrosylation. Science. 1998;279:234.PubMedCrossRefGoogle Scholar
- 29.Campbell DL, Stamler JS, Strauss HC: Redox modulation of L-type calcium channels in ferret ventricular myocytes. Dual mechanism regulation by nitric oxide and S-nitrosothiols. J Gen Physiol. 1996;108:277.PubMedCrossRefGoogle Scholar
- 30.Stamler JS, Jia L, Eu JP, McMahon TJ, Demchenko IT, Bonoventura J, Gernert K, Piantadosi CA. Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient. Science. 1997;276:2034.PubMedCrossRefGoogle Scholar
- 31.Busconi L, Michel T: Endothelial nitric oxide synthase. N-terminal myristoylation determines subcellular localization. J Biol Chem. 1993;268:8410.PubMedGoogle Scholar
- 32.Shaul PW, Smart EJ, Robinson LJ, German Z, Yuhanna IS, Ying Y, Anderson R, Michel T. Acylation targets endothelial nitric-oxide synthase to plasmalemmal caveolae. J Biol Chem. 1996;271:6518.PubMedCrossRefGoogle Scholar
- 33.Garcia-Cardena G, Oh P, Liu J, Schnitzer JE, Sessa WC. Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implications for nitric oxide signaling. Proc Natl Acad Sci USA. 1996;93:6448.PubMedCrossRefGoogle Scholar
- 34.Couet J, Li S, Okamoto T, Ikezu T, Lisanti MP. Identification of peptide and protein ligands for the caveolin-scaffoliding domain, implications for the interaction of caveolin with caveolae-associated proteins. J Biol Chem. 1997;272:6525.PubMedCrossRefGoogle Scholar
- 35.Michel JB, Feron O, Sase K, Prabhakar P, Michel T. Caveolin versus calmodulin. counterbalancing allosteric modulators of endothelial nitric oxide synthase. J Biol Chem. 1997;272:25907.PubMedCrossRefGoogle Scholar
- 36.Garcia-Cardena G, Fan R, Shah V, Sorrentino R, Cirino G, Papapetropoulos A, Sessa WC. Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature. 1998;392:821.PubMedCrossRefGoogle Scholar
- 37.Ludmer PL, Selwyn AP, Shook TL, Wayne RR, Mudge GH, Alexander RW, Ganz P. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med. 1986;315:1046.PubMedCrossRefGoogle Scholar
- 38.Nitenberg A, Valensi P, Sachs R, Dali M, Aptecar E, Attali JR. Impaiment of coronary vascular reserve and ACh-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function. Diabetes. 1993;42:1017.PubMedCrossRefGoogle Scholar
- 39.Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation. 1993;87:1468.PubMedCrossRefGoogle Scholar
- 40.Anderson TJ, Uehata A, Gerhard MD, Meredith IT, Knab S, Delagrange D, Lieberman EH, Gamz P, Creager MA, Yeung AC, Selwyn AP. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol. 1995;26:1235.PubMedCrossRefGoogle Scholar
- 41.Celermajer DS, Sorensen K, Ryalls M, Robinson J, Thomas O, Leonard JV, Deanfield JE. Impaired endothelial function occurs in the systemic arteries of children with homozygous homocystinuria but not in their heterozygous parents. J Am Coll Cardiol. 1993;22:854.PubMedCrossRefGoogle Scholar
- 42.Creager MA, Cooke JP, Mendelsohn ME, Gallagher SJ, Coleman SM, Loscalzo J, Dzau VJ. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest. 1990;86:228.PubMedCrossRefGoogle Scholar
- 43.Johnstone MT, Gallagher MT, Scales KM, Cusco JA, Lee B, Creagher M. Endotheliumdependent vasodilation is impaired in patients with insulin-dependent diabetes mellitus. Circulation. 1992;86:1–618.CrossRefGoogle Scholar
- 44.Vita JA, Treasure CB, Nabel EG, McLenachan JM, Fish RD, Yeung AC, Vekshtein VI, Selwyn AP, Ganz P. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation. 1990;81:491.PubMedCrossRefGoogle Scholar
- 45.Celermajer DS, Sorensen KE, Bull C, Ribinson J, Deanfield JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol. 1994;24:1468.PubMedCrossRefGoogle Scholar
- 46.Kugiyama K, Yasue H, Ihgushi M, Motoyama T, Dawano H, Inobe Y, Hirachima O, Sugiyama S. Deficiency in nitric oxide bioactivity in epicardial coronary arteries of cigarette smokers. J Am Coll Cardiol. 1996;28:1161.PubMedCrossRefGoogle Scholar
- 47.Clarkson P, Celermajer DS, Powe AJ, Donald AE, Henry RMA, Deanfield JE. Endotheliumdependent dilatation is impaired in young healthy subjects with a family history of premature coronary disease. Circulation. 1997;96:3378.PubMedCrossRefGoogle Scholar
- 48.Diaz M, Frei B, Vita JA, Keaney JF, Jr. Antioxidants and atherosclerotic heart disease. N Engl J Med. 1997;337:408.PubMedCrossRefGoogle Scholar
- 49.Heistad DD, Armstrong ML, Marcus ML, Piegors KJ, Mark AL. Augmented responses to vasoconstrictor stimuli in hypercholesterolemic and atherosclerotic monkeys. Circ Res. 1984;54:711.PubMedCrossRefGoogle Scholar
- 50.Henry PD, Yokoyama M. Supersensitivity of atherosclerotic rabbit aorta to ergonovine mediated by a serotonergic mechanism. J Clin Invest. 1980;66:306.PubMedCrossRefGoogle Scholar
- 51.Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288:373.PubMedCrossRefGoogle Scholar
- 52.Jayakody RL, Senaratne MPJ, Thomson ABR, Kappagoda CT. Cholesterol feeding impairs endothelium-dependent relaxation of rabbit aorta. Can J Physiol Pharmacol. 1985;63:1206.PubMedCrossRefGoogle Scholar
- 53.Freiman PC, Mitchell GG, Heistad DD, Armstrong ML, Harrison DG. Atherosclerosis impairs endothelium-dependent vascular relaxation to acetylcholine and thrombin in primates. Circ Res. 1986;58:783.PubMedCrossRefGoogle Scholar
- 54.Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA. 1987;84:9265.PubMedCrossRefGoogle Scholar
- 55.Minor RL, Jr., Myers PR, Guerra R, Jr., Bates JN, Harrison DG. Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. J Clin Invest. 1990;86:2109.PubMedCrossRefGoogle Scholar
- 56.Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial Superoxide anion production. J Clin Invest. 1993;91:2546.PubMedCrossRefGoogle Scholar
- 57.Keaney JF, Jr., Xu A, Cunningham D, Jackson T, Frei B, Vita JA. Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and Superoxide generation. J Clin Invest. 1995;95:2520.PubMedCrossRefGoogle Scholar
- 58.Kissner R, Nauser T, Bugnon P, Lye PG, Koppenol WH. Formation and properties of peroxynitrite as studied by laser flash photolysis, high-pressure stopped-flow technique, and pulse radiolysis. Chem Res Toxicol. 1997;10:1285.PubMedCrossRefGoogle Scholar
- 59.Leeuwenburgh C, Hansen P, Shaish A, Holloszy JO, Heinecke JW. Markers of protein oxidation by hydroxyl radical and reactive nitrogen species in tissues of aging rats. Am J Physiol. 1998;274:R453.PubMedGoogle Scholar
- 60.Ischiropoulos H, Zhu L, Beckman JS. Peroxynitrite formation from macrophage-derived nitric oxide. Arch Biochem Biophys. 1992;298:446.PubMedCrossRefGoogle Scholar
- 61.Mayer B, Schrammel A, Klatt P, Koesling D, Schmidt K. Peroxynitrite-induced accumulation of cyclic GMP in endothelial cells and stimulation of purified soluble guanylyl cyclase. Dependence on glutathione and possible role of S-nitrosation. J Biol Chem. 1995;270:17355.PubMedCrossRefGoogle Scholar
- 62.Tarpey MM, Beckman JS, Ischiropoulos H, Gore JZ, Brock TA. Peroxynitrite stimulates vascular smooth muscle cell cyclic GMP synthesis. FEBS Lett. 1995;364:314.PubMedCrossRefGoogle Scholar
- 63.Rosen GM, Freeman BA. Detection of Superoxide generated by endothelial cells. Proc Natl Acad Sci USA. 1984;81:7269.PubMedCrossRefGoogle Scholar
- 64.Rubanyi GM, Vanhoutte PM. Superoxide anions and hyperoxia inactivate endotheliumderived relaxing factor. Am J Physiol. 1986;250:H822.PubMedGoogle Scholar
- 65.Gryglewski RJ, Palmer RM, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature. 1986;320:454.PubMedCrossRefGoogle Scholar
- 66.Ignarro LJ, Byrns RE, Buga GM, Wood KS, Chaudhuri G. Pharmacological evidence that endothelium-derived relaxing factor is nitric oxide: use of pyrogallol and Superoxide dismutase to study endothelium dependent and nitric oxide elicited vascular smooth muscle relaxation. J Pharmacol Exp Ther. 1988;244:181.PubMedGoogle Scholar
- 67.Heikkila RE, Cohen G. The inactivation of copper-zinc Superoxide dismutase by diethyldithiocarbamate, in Anonymous Superoxide and Superoxide Dismutases. New York, Academic Press, 1977, p 367.Google Scholar
- 68.Omar HA, Cherry PD, Mortelliti MP, Burke-Wolin T, Wolin MS. Inhibition of coronary artery Superoxide dismutase attenuates endothelium-dependent and-independent nitrovasodilator relaxation. Circ Res. 1991;69:601.PubMedCrossRefGoogle Scholar
- 69.Mugge A, Elwell JK, Peterson TE, Harrison DG. Release of intact endothelium-derived relaxing factor depends on endothelial Superoxide dismutase activity. Am J Physiol. 1991;260:C219.PubMedGoogle Scholar
- 70.Mulsch A, Mordvintcev P, Bassenge E, Jung F, Clement B, Busse R. In vivo spin trapping of glyceryl trinitrate-derived nitric oxide in rabbit blood vessels and organs. Circulation. 1995;92:1876.PubMedCrossRefGoogle Scholar
- 71.Sarvazyan N, Askari A, Klevay LM, Huang WH. Role of intracellular SOD in oxidantinduced injury to normal and copper-deficient cardiac myocytes. Am J Physiol. 1995;268:H1115.PubMedGoogle Scholar
- 72.Lynch SM, Frei B, Morrow JD, Roberts LJ, II, Xu A, Jackson T, Reyna R, Klevay LM, Vita JA, Keaney JF, Jr. Vascular Superoxide dismutase deficiency impairs endothelial vasodilator function through direct inactivation of nitric oxide and increased lipid peroxidation. Arterioscler Thromb Vasc Biol. 1997;17:2975.PubMedCrossRefGoogle Scholar
- 73.Schuschke DA, Ree MWR, Saari JT, Miller FN: Copper deficiency alters vasodilation in the rat cremaster muscle microcirculation. J Nutr. 1992; 122:1547.PubMedGoogle Scholar
- 74.Abrahamsson T, Brandt U, Marklund SL, Sjoqvist PO. Vascular bound recombinant extracellular Superoxide dismutase type C protects against the detrimental effects of Superoxide radicals on endothelium-dependent arterial relaxation. Circ Res. 1992;70:264.PubMedCrossRefGoogle Scholar
- 75.Mugge A, Elwell JH, Peterson TE, Hofmeyer TG, Heistad DD, Harrison DG. Chronic treatment with polyethylene-glycolated Superoxide dismutase partially restores endotheliumdependent vascular relaxations in cholesterol-fed rabbits. Circ Res. 1991;69:1293.PubMedCrossRefGoogle Scholar
- 76.White CR, Brock TA, Chang LY, Crapo J, Briscoe P, Ku D, Bradley WA, Gianturco SH, Gore J, Freeman BA, Tarpey MM. Superoxide and peroxynitrite in atherosclerosis. Proc Natl Acad Sci USA. 1994;91:1044.PubMedCrossRefGoogle Scholar
- 77.Pagano PJ, Ito Y, Tornheim K, Gallop P, Tauber AI, Cohen RA. An NADPH oxidase Superoxide generating system in rabbit aorta. Am J Physiol. 1995;268:H2274.PubMedGoogle Scholar
- 78.Pagano PJ, Clark J, Cifuentes-Pagano ME, Clark SM, Callis GM, Quinn MT. Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II. Proc Natl Acad Sci USA. 1997;94:14483.PubMedCrossRefGoogle Scholar
- 79.Mojazzab H, Kaminski PM, Wolin MS: NADH oxidoreductase is a major source of Superoxide anion in bovine coronary artery endothelium. Am J Physiol. 1994;266:H2568.Google Scholar
- 80.Kukreja RC, Kontos HA, Hess ML, Ellis EF. PGH synthase and lipoxygenase generate Superoxide in the presence of NADH or NADPH. Circ Res. 1986;59:612.PubMedCrossRefGoogle Scholar
- 81.Paler-Martinez A, Panus PC, Chumley PH, Ryan US, Hardy MM, Freeman BA. Endogenous xanthine oxidase does not significantly contribute to vascular endothelial production of reactive oxygen species. Arch Biochem Biophys. 1994;311:79.PubMedCrossRefGoogle Scholar
- 82.White CR, Darley-Usmar V, Berrington WR, McAdams M, Gore JZ, Thompson JA, Parks DA, Tarpey MM, Freeman BA. Circulating plasma xanthine oxidase contributes to vascular dysfunction in hypercholesterolemic rabbits. Proc Natl Acad Sci USA. 1996;93:8745.PubMedCrossRefGoogle Scholar
- 83.Cardillo C, Kilcoyne CM, Cannon RO, III, Quyyumi AA, Panza JA. Xanthine oxidase inhibition with oxypurinol improves endothelai fasodilator function in hypercholesterolemic but not in hypertensive patients. Hypertension. 1997;30:57.PubMedCrossRefGoogle Scholar
- 84.Pou S, Pou WS, Bredt DS, Snyder SH, Rosen GM. Generation of Superoxide by purified brain nitric oxide synthase. J Biol Chem. 1992;267:24173.PubMedGoogle Scholar
- 85.Vasquez-Vivar J, Kalyanaraman B, Martasek P, Hogg N, Masters BS, Karoui H, tordo P, Pritchard KA, Jr. Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc Natl Acad Sci USA. 1998;95:9220.PubMedCrossRefGoogle Scholar
- 86.Xia Y, Roman LJ, Masters BS, Zweier JL. Inducible nitric-oxide synthase generates Superoxide from the reductase domain. J Biol Chem. 1998;273:22635.PubMedCrossRefGoogle Scholar
- 87.Pritchard KA, Jr., Groszek L, Smalley DM, Sessa WC, Wu M, Villalon P, Wolin MS, Stemerman MB. Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of Superoxide anion. Circ Res. 1995;77:510.PubMedCrossRefGoogle Scholar
- 88.Stroes E, Kastelein J, Cosentino F, Erkelens W, Wever R, Koomans H, Luscher T, Rabelink T. Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. J Clin Invest. 1996;99:41.CrossRefGoogle Scholar
- 89.Verhaar MC, Wever RM, Kastelein JJ, van Dam T, Koomans HA, Rabelink TJ. 5-methyltetrahydrofolate, the active form of folic acid, restores endothelial function in familial hypercholesterolemia. Circulation. 1998;97:237.PubMedCrossRefGoogle Scholar
- 90.Kagota S, Yamaguchi Y, Shinozuka K, Kunitomo M. Mechanisms of impairment of endothelium-dependent relaxation to acetylcholine in Watanabe heritable hyperlipidemic rabbit aortas. Clin Exper Pharmacol Physiol. 1998;25:104.CrossRefGoogle Scholar
- 91.Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and Superoxide. Proc Natl Acad Sci USA. 1990;87:1620.PubMedCrossRefGoogle Scholar
- 92.Saran M, Michel C, Bors W: Reaction of NO with O2-. Implications for the action of endothelium-derived relaxing factor (A2RF). Free Radie Res Commun. 1990;10:221.CrossRefGoogle Scholar
- 93.Beckman JS, Crow JP. Pathological implications of nitric oxide, Superoxide, and peroxynitrite formation. Biochem Soc Trans. 1993;21:330.PubMedGoogle Scholar
- 94.Moreno JJ, Pryor WA: Inactivation of a-1-proteinase inhibitor by peroxynitrite. Chem Res Toxicol. 1992;5:425.PubMedCrossRefGoogle Scholar
- 95.Graham A, Hogg N, Kalyanaraman B, O’Leary V, Darley-Usmar V, Moncada S: Peroxynitrite modification of low-density lipoprotein leads to recognition by the macrophage scavenger receptor. FEBS Lett. 1993;330:181.PubMedCrossRefGoogle Scholar
- 96.Landino LM, Crews BC, Timmons MD, Morrow JD, Marnett LJ. Peroxynitrite, the couling product of nitric oxide and Superoxide, activates Prostaglandin biosynthesis. Proc Natl Acad Sci U.S.A. 1996;93:15069.PubMedCrossRefGoogle Scholar
- 97.Ischiropoulos H, Zhu L, Chen J, Tsai M, Martin JC, Smith CD, Beckman JS. Peroxynitritemediated tyrosine nitration catalyzed by Superoxide dismutase. Arch Biochem Biophys. 1992;298:431.PubMedCrossRefGoogle Scholar
- 98.Buettner GR. The pecking order of free radicals and antioxidants: lipid peroxidation, alphatocopherol, and ascorbate. Arch Biochem Biophys. 1993;300:535.PubMedCrossRefGoogle Scholar
- 99.Lynch SM, Frei B: Mechanisms of copper-and iron-dependent oxidative modification of human low-density lipoprotein. J Lipid Res. 1993;34:1745.PubMedGoogle Scholar
- 100.Haber F, Weiss J: The catalytic decomposition of hydrogen peroxide by iron salts. Proc Roy Soc London 1934,147:332.CrossRefGoogle Scholar
- 101.Ehrenwald E, Chisolm GM, Fox PL. Intact human ceruloplasmin oxidatively modifies low density lipoprotein. J Clin Invest. 1994;93:1493.PubMedCrossRefGoogle Scholar
- 102.Smith C, Mitchinson MJ, Aruoma OI, Halliwell B. Stimulation of lipid peroxidation and hydroxyl radical generation by the contents of human atherosclerotic lesions. Biochem J 1992;286:901.PubMedGoogle Scholar
- 103.Semenkovich CF, Heinecke JW. The mystery of diabetes and atherosclerosis: time for a new plot. Diabetes. 1997;46:327.PubMedCrossRefGoogle Scholar
- 104.Heinecke JW, Li W, Francis GA, Goldstein JA. Tyrosyl radical generated by myeloperoxidase catalyzes the oxidative cross-linking of proteins. J Clin Invest. 1993;91:2866.PubMedCrossRefGoogle Scholar
- 105.Heinecke JW: Pathways for oxidation of low density lipoprotein by meloperoxidase: tyrosyl radical, reactive aldehydes, hypochlorous acid, and molecular chlorine. Biofactors 1997;6:145.PubMedCrossRefGoogle Scholar
- 106.Daugherty A, Rateri DL, Dunn JL, Heinecke JW. Human atherosclerotic lesions contain myeloperoxidase, a phagocyte enzyme that catalyzes oxidation reactions. Circulation. 1993;88:1-32.Google Scholar
- 107.Hazen SL, Heinecke JW. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J Clin Invest. 1997;99:2075.PubMedCrossRefGoogle Scholar
- 108.Folcik VA, Nivar-Aristy RA, Krajewski LP, Cathcart MK: Lipoxygenase contributes to the oxidation of lipids in human atherosclerotic plaques. J Clin Invest. 1995;96:504.PubMedCrossRefGoogle Scholar
- 109.Loscalzo J. The oxidant stress of hyperhomocyst(e)inemia. J Clin Invest. 1996;98:5.PubMedCrossRefGoogle Scholar
- 110.Malle E, Hazell L, Stocker R, Sattler W, Esterbauer H, Waeg G: Immunologic detection and measurement of hypochlorite-modified LDL with specific monoclonal antibodies. Arterioscler Thromb Vasc Biol. 1995;15:982.PubMedCrossRefGoogle Scholar
- 111.Wagner BA, Buettner GR, Burns CP. Free radical-mediated lipid peroxidation in cells: oxidizability is a function of cell lipid bis-allylic hydrogen content. Biochemistry. 1994;33:4449.PubMedCrossRefGoogle Scholar
- 112.Keaney JF, Jr., Frei B. Antioxidant protection of low-density lipoprotein and its role in the prevention of atherosclerotic vascular disease, in Frei B (ed): Natural antioxidants in human health and disease. San Diego, Academic Press, 1994, p 303.Google Scholar
- 113.Padmaja S, Huie RE: The reaction of nitric oxide with organic peroxyl radicals. Biochem Biophys Res Commun. 1993;195:539.PubMedCrossRefGoogle Scholar
- 114.Rubbo H, Radi R, Trujillo M, Telleri R, Kalyanaraman B, Barnes S, Kirk M, Freeman BA: Nitric oxide regulation of Superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives. J Biol Chem. 1994;269:26066.PubMedGoogle Scholar
- 115.Ylä-Herttuala S, Palinski W, Rosenfeld ME, Parthasarathy S, Carew TE, Butler S, Witztum JL, Steinberg D: Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest. 1989;84:1086.PubMedCrossRefGoogle Scholar
- 116.Chin JH, Azhar S, Hoffman BB: Inactivation of endothelium-derived relaxing factor by oxidized lipoproteins. J Clin Invest. 1992;89:10.PubMedCrossRefGoogle Scholar
- 117.Liao JK, Shin WS, Lee WY, Clark SL. Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase. J Biol Chem. 1995;270:319.PubMedCrossRefGoogle Scholar
- 118.Ohgushi M, Kugiyama K, Fukunaga K, Murohara T, Sugiyama S, Miyamoto E, Yasue H: Protein kinase C inhibitors prevent impairment of endothelium-dependent relaxation by oxidatively modified LDL. Arterioscler Thromb. 1993;13:1525.PubMedCrossRefGoogle Scholar
- 119.Kugiyama K, Kerns SA, Morrisett JD, Roberts R, Henry PD: Impairment of endotheliumdependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature. 1990;344:160.PubMedCrossRefGoogle Scholar
- 120.Liu J, Garcia-Cardena G, Sessa WC. Palmitoylation of endothelial nitric oxide synthase is necessary for optimal stimulatted release of nitric oxide: implications for caveolae localization. Biochemistry. 1996;35:13277.PubMedCrossRefGoogle Scholar
- 121.Wink DA, Hanbauer I, Krishna MC, DeGraff W, Gamson J, Mitchell JB. Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species. Proc Natl Acad Sci USA. 1993;90:9813.PubMedCrossRefGoogle Scholar
- 122.Hogg N, Kalyanaraman B, Joseph J, Struck A, Parthasarathy S. Inhibition of low-density lipoprotein oxidation by nitric oxide. Potential role in atherogenesis. FEBS Lett. 1993;334:170.PubMedCrossRefGoogle Scholar
- 123.Zembowicz A, Hatchett RJ, Jakubowski AM, Gryglewski RJ. Involvement of nitric oxide in the endothelium-dependent relaxation induced by hydrogen peroxide in rabbit aorta. Br J Pharmacol. 1993;110:151.PubMedCrossRefGoogle Scholar
- 124.Okuma M, Steiner M, Bladini MG. Studies on lipid peroxides in platelets. II. Effect of aggregating agents and platelet antibody. J Lab Clin Med. 1971;77:728.PubMedGoogle Scholar
- 125.Freedman JE, Frei B, Welch GN, Loscalzo J. Glutathione peroxidase potentiates the inhibition of platelet function by S-nitrosothiols. J Clin Invest. 1995;96:394.PubMedCrossRefGoogle Scholar
- 126.Esterbauer H, Striegl G, Puhl H, Oberreither S, Rotheneder M, el-Saadani M, Jürgens J. The role of vitamin E and carotenoids in preventing oxidation of low density lipoprotein. Ann NY Acad Sci. 1989;570:254.PubMedCrossRefGoogle Scholar
- 127.Jialal I, Norkus EP, Cristol L, Grundy SM. Beta-carotene inhibits the oxidative modification of low density lipoprotein. Biochim Biophys Acta. 1991;1086:134.PubMedCrossRefGoogle Scholar
- 128.Gaziano JM, Hatta A, Flynn M, Johnson EJ, Krinsky NI, Ridker PM, Hennekens CH, Frei B. Supplementation with beta-carotene in vivo and in vitro does not inhibit low density lipoprotein (LDL) oxidation. Atherosclerosis 1995;112:187.PubMedCrossRefGoogle Scholar
- 129.Verbeuren TJ, Jordaens FH, Zonnekeyn LL, Van Hove CE, Coene MC, Herman AG. Effect of hypercholesterolemia on vascular reactivity in the rabbit. Circ Res. 1986;58:553.CrossRefGoogle Scholar
- 130.Keaney JF, Jr., Gaziano JM, Xu A, Frei B, Curran-Celantano J, Shwaery GT, Loscalzo J, Vita JA. Dietary antioxidants preserve endothelium-dependent vessel relaxation in cholesterol-fed rabbits. Proc Natl Acad Sci USA. 1993;90:11880.PubMedCrossRefGoogle Scholar
- 131.Andersson TLG, Matz J, Ferns GAA, Änggård EE. Vitamin E reverses cholesterol-induced endothelial dysfunction in the rabbit coronary circulation. Atherosclerosis 1994;111:39.PubMedCrossRefGoogle Scholar
- 132.Stewart-Lee AL, Forster LA, Nourooz-Zadeh J, Ferns GAA, Änggård EE. Vitamin E protects against impairment of endothelium-mediated relaxations in cholesterol-fed rabbits. Arterioscler Thromb. 1994;14:494.PubMedCrossRefGoogle Scholar
- 133.Lutz M, Cortez J, Vinet R. Effects of dietary fats, alpha-tocopherol and beta-carotene supplementation on aortic ring segment responses in the rat. Int J Vit Nutr Res 1995;65:225.Google Scholar
- 134.Raij L, Jagy J, Coffee K, DeMaster EG. Hypercholesterolemia promotes endothelial dysfunction in vitamin E-and selenium-deficient rats. Hypertension. 1993;22:56.PubMedCrossRefGoogle Scholar
- 135.Keegan A, Walbank H, Cotter MA, Cameron NE. Chronic vitamin E treatment prevents defective endothelium-dependent relaxation in diabetic rat aorta. Diabetologia 1995;38:1475.PubMedCrossRefGoogle Scholar
- 136.Karasu C, Ozansoy G, Bozkurt O, Erdogan D, Omeroglu S. Changes in isoprenaline-induced endothelium-dependent and-independent relaxations of aorta in long-term STZ-diabetic rats: reversal effect of dietary vitamin E. Gen Pharm 1997;29:561.CrossRefGoogle Scholar
- 137.Karasu C, Ozansoy G, Bozkurt O, Erdogan D, Omeroglu S. Antioxidant and triglyceridelowering effects of vitamin E associated with the prevention of abnormalities in the reactivity and morphology of aorta from streptozotocin-diabetic rats. Antioxidants in Diabetes-Induced Complications (ADIC) Study Group. Metabolism 1997;46:872.PubMedCrossRefGoogle Scholar
- 138.Rosen P, Ballhausen T, Stockklauser K. Impairment of endothelium dependent relaxation in the diabetic rat heart: mechanisms and implications. Diabetes Res Clin Pract 1996;31 Suppl:S143.PubMedCrossRefGoogle Scholar
- 139.Gopaul NK, Änggård EE, Mallet AI, Betteridge DJ, Wolff SP, Nourooz-Zadeh J. Plasma 8-epi-PGF2alpha levels are elevated in individuals with non-insulin dependent diabetes mellitus. FEBS Lett. 1995;368:225.PubMedCrossRefGoogle Scholar
- 140.Davi G, Ciabottoni G, Consoli A, Messetti A, Falco A, Santarone S, Pennese E, Vitacolonna E, Bucciarelli T, Costantini F, Capani F, Patrono C. In vivo formation of 8-iso-prostaglandin F2alpha and platelet activation in diabetes mellitus, effects of improved metabolic control. Circulation. 1998;98:in pressGoogle Scholar
- 141.Keaney JF, Jr., Loscalzo J. Oxidative stress, diabetes, and platelet activation. Circulation. 1999;98:in pressGoogle Scholar
- 142.Dieber-Rotheneder M, Puhl H, Waeg H, Striegl G, Esterbauer H. Effect of oral supplementation with D-alpha-tocopherol on the vitamin E content of human low density lipoproteins and resistance to oxidation. J Lipid Res. 1991;32:1325.PubMedGoogle Scholar
- 143.Keaney JF, Jr., Gaziano JM, Xu A, Frei B, Curran-Celentano J, Shwaery GT, Loscalzo J, Vita JA. Low-dose α-tocopherol improves and high-dose α-tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits. J Clin Invest. 1994;93:844.PubMedCrossRefGoogle Scholar
- 144.Suarna C, Dean RT, May J, Stocker R: Human atherosclerotic plaque contains both oxidized lipids and relatively large amounts of α-tocopherol and ascorbate. Arterioscler Thromb Vasc Biol. 1995;15:1616.PubMedCrossRefGoogle Scholar
- 145.Keaney JF, Jr., Guo Y, Cunningham D, Shwaery GT, Xu A, Vita JA. Vascular incorporation of α-tocopherol prevents endothelial dysfunction due to oxidized LDL by inhibiting protein kinase C stimulation. J Clin Invest. 1996;98:386.PubMedCrossRefGoogle Scholar
- 146.Williams B, Schrier RW. Characterization of glucose-induced in situ protein kinase C activity in cultured vascular smooth muscle cells. Diabetes. 1992;41:1464.PubMedCrossRefGoogle Scholar
- 147.Jay MT, Chirico S, Siow RC, Bruckdorfer KR, Jacobs M, Leake DS, Pearson JD, Mann GE. Modulation of vascular tone by low density lipoproteins: effects on L-arginine transport and nitric oxide synthesis. Exp Physiol 1997;82:349.PubMedGoogle Scholar
- 148.Kugiyama K, Ohgushi M, Sugiyama S, Murohara T, Fukunaga K, Miyamoto E, Yasue H. Lysophosphatidylcholine inhibits surface receptor-mediated intracellular signals in endothelial cells by a pathway involving protein kinase C activation. Circ Res. 1992;71:1422.PubMedCrossRefGoogle Scholar
- 149.Sugiyama S, Kugiyama K, Ohgushi M, Fujimoto K, Yasue H. Lysophosphatidylcholine in oxidized low-density lipoprotein increases endothelial susceptibility to polymorphonuclear leukocyte-induced endothelial dysfunction in porcine coronary arteries: role of protein kinase C. Circ Res. 1994;74:565.PubMedCrossRefGoogle Scholar
- 150.Flavahan NA, Shimokawa H, Vanhoutte PM. Inhibition of endothelium-dependent relaxations by phorbol myristate acetate in canine coronary arteries: role of a pertussus toxin-sensitive G-protein. J Pharmacol Exp Ther. 1991;256:50.PubMedGoogle Scholar
- 151.Boscoboinik D, Szewczyk A, Hensey C, Azzi A. Inhibition of cell proliferation by a-tocopherol. J Biol Chem. 1991;266:6188PubMedGoogle Scholar
- 152.Freedman JE, Farhat JH, Loscalzo J, Keaney JF, Jr. α-Tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism. Circulation. 1996;94:2434.PubMedCrossRefGoogle Scholar
- 153.Marshall FN: Pharmacology and toxicology of probucol. Artery 1982;10:7.PubMedGoogle Scholar
- 154.Shaish A, Daugherty A, O’Sullivan F, Schonfeld G, Heinecke JW: Beta-carotene inhibits atherosclerosis in hypercholesterolemic rabbits. J Clin Invest. 1995;96:2075.PubMedCrossRefGoogle Scholar
- 155.Parthasarathy S, Young SG, Witztum JL, Pittman RC, Steinberg D: Probucol inhibits oxidative modification of low density lipoprotein. J Clin Invest. 1986;77:641.PubMedCrossRefGoogle Scholar
- 156.Carew TE, Schwenke DC, Steinberg D: Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Proc Natl Acad Sci USA. 1987;84:7725.PubMedCrossRefGoogle Scholar
- 157.Kita T, Nagano Y, Yokode M, Ishii K, Kume N, Ooshima A, Yoshida H, Kawai C: Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc Natl Acad Sci USA. 1987;84:5928.PubMedCrossRefGoogle Scholar
- 158.Sasahara M, Raines EW, Chait A, Carew TE, Steinberg D, Wahl PW, Ross R: Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol. Is the extent of atherosclerosis related to resistance of LDL to oxidation? J Clin Invest. 1994;94:155.PubMedCrossRefGoogle Scholar
- 159.Zhang SH, Reddick RL, Avdievich E, Surles LK, Jones RG, Reynolds JB, Quarfordt SH, Maeda N. Paradoxical enhancement of atherosclerosis by probucol treatment in apolipoprotein E-deficient mice. J Clin Invest. 1997;99:2858.PubMedCrossRefGoogle Scholar
- 160.Simon BC, Haudenschild CC, Cohen RA. Preservation of endothelium-dependent relaxation in atherosclerotic rabbit aorta by probucol. J Cardiovasc Pharmacol 1993;21:893.PubMedCrossRefGoogle Scholar
- 161.Inoue N, Ohara Y, Fukai T, Harrison DG, Nishida K: Probucol improves endothelialdependent relaxation and decreases vascular Superoxide production in cholesterol-fed rabbits. Am J Med Sci. 1998;315:242.PubMedCrossRefGoogle Scholar
- 162.Hoshida S, Yamashita N, Igarashi J, Aoki K, Kuzuya T, Hori M. Long-term probucol treatment reverses the severity of myocardial injury in watanabe heritable hyperlipidemic rabbits. Arterioscler Thromb Vasc Biol 1997;17:2801.PubMedCrossRefGoogle Scholar
- 163.Tesfamariam B, Cohen RA. Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am J Physiol. 1992;263:H321.PubMedGoogle Scholar
- 164.Flavahan NA. Atherosclerosis or lipoprotein-induced endothelial dysfunction: potential mechanisms underlying reduction in A2RF/nitric oxide activity. Circulation. 1992;85:1927.PubMedCrossRefGoogle Scholar
- 165.McDowell IFW, Brennan GM, McEneny J, Young IS, Nicholls DP, McVeigh GE, Bruce I, Trimble ER, Johnston GD: The effect of probucol and vitamin E treatment on the oxidation of low-density lipoprotein and forearm vascular responses in humans. Eur J Clin Invest. 1994;24:759.PubMedCrossRefGoogle Scholar
- 166.Elliott TG, Barth JD, Mancini J. Effects of vitamin E on endothelial function in men after myocardial infarction. Am J Cardiol. 1995;76:1188.PubMedCrossRefGoogle Scholar
- 167.Gilligan DM, Sack MN, Guetta V, Casino PR, Quyyumi AA, Rader DJ, Panza JA, Cannon RO, II. Effect of antioxidant vitamins on low density lipoprotein oxidation and impaired endothelium-dependent vasodilation on patients with hypercholesterolemia. J Am Coll Cardiol. 1994;24:1611.PubMedCrossRefGoogle Scholar
- 168.Koh KK, Blum A, Schenke WH, Hathaway L, Mincemoyer R, Panza JA, Cannon RO, III. Vitamin E improves endothelium-dependent vasodilator responsiveness comparable to estrogen in postmenopausal women. Circulation 1998;98:111-3468.Google Scholar
- 169.Motoyama T, Kugiyama K, Doi H, Kawano K, Moriyama Y, Sakamoto T, Takazoe K, Yoshimura M, Hirai N, Ota Y. Vitamin E treatment improves impairment of endotheliumdependent vasodilation in patients with high remnant lipoprotein levels. Circulation 1998;98:111-904.Google Scholar
- 170.Wendel A, Cikryt P. The level and half-life of glutathione in human plasma. FEBS Lett. 1980;120:209.PubMedCrossRefGoogle Scholar
- 171.Bray TM, Taylor CG. Tissue glutathione, nutrition, and oxidative stress. Can J Physiol Pharmacol. 1993;71:746.PubMedCrossRefGoogle Scholar
- 172.Bergsten P, Yu R, Kehrl J, Levine M. Ascorbic acid transport and distribution in human B lymphocytes. Arch Biochem Biophys. 1994;317:208.CrossRefGoogle Scholar
- 173.Martensson J, Han J, Griffith EW, Meister A. Glutathione ester delays the onset of scurvy in ascorbate-deficient guinea pigs. Proc Natl Acad Sci USA. 1993;90:317.PubMedCrossRefGoogle Scholar
- 174.Martensson J, Meister A. Glutathione deficiency decreases tissue ascorbate levels in newborn rats: ascorbate spares glutathione and protects. Proc Natl Acad Sci USA. 1991;88:4656.PubMedCrossRefGoogle Scholar
- 175.Murphy ME, Piper HM, Watanabe H, Sies H: Nitric oxide production by cultured aortic endothelial cells in response to thiol depletion and replenishment. J Biol Chem. 1991;266:19378.PubMedGoogle Scholar
- 176.Hecker M, Seigle I, Macarthur H, Sessa WC, Vane JR. Role of intracellular thiols in release of EDRF from cultured endothelial cells. Am J Physiol. 1992;262:H888.PubMedGoogle Scholar
- 177.Ghigo D, Alessio P, Foco A, Bussolino F, Costamagna D, Heller R, Garbarino G, Pescarmona GP, Bosia A. Nitric oxide synthesis is impaired in glutathione depleted human umbilical vein endothelial cells. Am J Physiol. 1993;265:C728.PubMedGoogle Scholar
- 178.Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340:1111.PubMedCrossRefGoogle Scholar
- 179.Williamson JM, Meister A. Stimulation of hepatic glutathione formation by administration of L-2-oxothiazolidine-4-carboxylate: a 5-oxo-L-prolinase substrate. Proc Natl Acad Sci USA. 1981;78:936.PubMedCrossRefGoogle Scholar
- 180.Boesgaard S, Aldershvile J, Poulsen HE, Loft S, Anderson ME, Meister A. Nitrate tolerance in vivo is not associated with depletion of arterial or venous thiol levels, Circ Res. 1994;74:115.PubMedCrossRefGoogle Scholar
- 181.Vita JA, Frei B, Holbrook M, Gokce N, Leaf C, Keaney JF, Jr. L-2-Oxothiazolidine-4-carboxylic acid revereses endothelial dysfunction in patients with coronary artery disease. J Clin Invest. 1998;101:1408.PubMedCrossRefGoogle Scholar
- 182.Kugiyama K, Ohgushi M, Motoyama T, Hirashima O, Soejima H, Misumi K, Yoshimura M, Ogawa H, Sugiyama S, Yasue H. Intracoronary infusion of reduced glutathione improves endothelial vasomotor response to acetylcholine in human coronary circulation. Circulation 1998;97:2299.PubMedCrossRefGoogle Scholar
- 183.Stuehr DJ, Kwon NS, Nathan CF: FAD and GSH participate in macrophage synthesis of nitric oxide. Biochem Biophys Res Commun. 1990; 168:558.PubMedCrossRefGoogle Scholar
- 184.Komori Y, Hyun J, Chiang K, Fukuto JM. The role of thiols in the apparent activation of rat brain nitric oxide synthase (NOS). J Biochem. 1995;117:923.PubMedGoogle Scholar
- 185.Hofmann H, Schmidt HHHW. Thiol dependence of nitric oxide synthase. Biochemistry. 1995;34:13443.PubMedCrossRefGoogle Scholar
- 186.Gorren ACF, Schrammel A, Schmidt K, Mayer B. Thiols and neuronal nitric oxide synthase: complex formation, competitive inhibition, and enzyme stabilization. Biochemistry. 1997;36:4360.PubMedCrossRefGoogle Scholar
- 187.Fitzgerald DJ, Roy L, Catella F, FitzGerald GA: Platelet activation in unstable coronary disease. N Engl J Med. 1986;315:983.PubMedCrossRefGoogle Scholar
- 188.Ma XL, Lopez BL, Liu GL, Christopher TA, Gao F, Guo Y, Feuerstein GZ, Ruffolo J, Barone FC, Yue TL. Hypercholesterolemia impairs a detoxification mechanism againt peroxynitrite and renders the vascular tissue more susceptible to oxidative injury, Circ Res. 1997;80:894.PubMedCrossRefGoogle Scholar
- 189.Howells DW, Hyland K. Direct analysis of tetrahydrobiopterin in ceribrospinal fluid by highperfomrmance liquid chromatography with redox electrochemistry: prevention of autoxidation during storage and analysis. Clin Chim Acta. 1987;167:23.PubMedCrossRefGoogle Scholar
- 190.Heales S, Hyland K. Determination of quinonoid dihydrobiopterin by high-performance liquid chromatrography and electrochemical detection. J Chromatogr. 1989;494:77.PubMedCrossRefGoogle Scholar
- 191.Patel JM, Abeles AJ, Block ER. Nitric oxide exposure and sulfhydryl modulation alter L-arginine transport in cultured pulmonary artery endothelial cells. Free Radic Biol Med. 1996;20:629.PubMedCrossRefGoogle Scholar
- 192.Xia Y, Dawson VL, Dawson TM, Snyder SH, Zweier JL. Nitric oxide synthase generates Superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cell injury. Proc Natl Acad Sci USA. 1996;93:6770.PubMedCrossRefGoogle Scholar
- 193.Heinzel B, John M, Klatt P, hme E, Mayer B. Ca2+/calmodulin-dependent formation of hydrogen peroxide by brain nitric oxide synthase. Biochem J. 1992;281:627.PubMedGoogle Scholar
- 194.Nishikimi M. Oxidation of ascorbic acid with Superoxide anion generated by the xanthinexanthine oxidase system. Biochem Biophys Res Commun. 1975;63:463.PubMedCrossRefGoogle Scholar
- 195.Bodannes RS, Chan PC. Ascorbic acid as a scavenger of singlet oxygen. FEBS Lett. 1979;105:195.PubMedCrossRefGoogle Scholar
- 196.Halliwell B, Wasil M, Grootveld M. Biologically significant scavenging of the myeloperoxidase-derived oxidant hypochlorous acid by ascorbic acid. Implications for antioxidant protection in the inflamed rheumatoid joint. FEBS Lett. 1987;213:15.PubMedCrossRefGoogle Scholar
- 197.Frei B, England L, Ames BN. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci USA. 1989;86:6377.PubMedCrossRefGoogle Scholar
- 198.Levine GN, Frei B, Koulouris SN, Gerhard MD, Keaney JF, Jr., Vita JA. Ascorbic acid reverses endothelial dysfunction in patients with coronary artery disease. Circulation. 1996;96:1107.CrossRefGoogle Scholar
- 199.Ting HH, Timimi FK, Boles KS, Creager SJ, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest. 1996;97:22.PubMedCrossRefGoogle Scholar
- 200.Ting HH, Timimi FK, Haley EA, Roddy MA, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholerolemia. Circulation. 1997;95:2617.PubMedCrossRefGoogle Scholar
- 201.Heitzer T, Just H, Munzel T. Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. Circulation. 1996;94:6.PubMedCrossRefGoogle Scholar
- 202.Hornig B, Arakawa N, Kohler C, Drexler H. Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure. Circulation. 1998;97:363.PubMedCrossRefGoogle Scholar
- 203.Motoyama T, Kawano H, Hirai N. Vitamin E administration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina. Circulation 1998;98:111–4464Google Scholar
- 204.Jackson TS, Xu A, Vita JA, Keaney JF, Jr. Ascorbic acid prevents the interaction of nitric oxide and Superoxide only at very high physiologic concentrations, Circ Res. 1998;83:916.PubMedCrossRefGoogle Scholar
- 205.O’Keefe JH, Jr., Stone GW, McCallister BD, Jr., Maddex C, Ligon R, Kacich RL, Kahn J, Cavero PG, Hartzler GO, Mccallister BD. Lovistatin plus probucol for prevention of restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol. 1996;77:649.PubMedCrossRefGoogle Scholar
- 206.Jain A, Martensson J, Mehta T, Krauss AN, Auld PA, Meister A. Ascorbic acid prevents oxidative stress in glutathione-deficient mice: effects on lung type 2 cell lamellar bodies, lung survactant, and skeletal muscle. Proc Natl Acad Sci USA. 1992;89:5093.PubMedCrossRefGoogle Scholar
- 207.Boulanger CM, Tanner FC, Bea ML, Hahn AWA, Werner A, Luscher TF. Oxidized low density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium. Circ Res. 1992;70:1191.PubMedCrossRefGoogle Scholar
- 208.Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411.PubMedCrossRefGoogle Scholar
- 209.Masaki T, Yanagisawa M, Goto K. Physiology and pharmacology of endothelins. Med Res Rev. 1992;12:391.PubMedCrossRefGoogle Scholar
- 210.Steinbrecher UP, Parthasarathy S, Leake DS, Witztum JL, Steinberg D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci USA. 1984;81:3883.PubMedCrossRefGoogle Scholar
- 211.Kugiyama K, Sakamoto T, Misumi I, Sugiyama S, Ohgushi M, Ogawa H, Horiguchi M, Yasue H. Transferable lipids in oxidized low-density lipoprotein stimulate Plasminogen activator inhibitor-1 and inhibit tissue-type Plasminogen activator release from endothelial cells. Circ Res. 1993;73:335.PubMedCrossRefGoogle Scholar
- 212.Marui N, Offermann MK, Swerlick R, Kunsch C, Rosen CA, Ahmad M, Alexander RW, Medford RM. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest. 1993;92:1866.PubMedCrossRefGoogle Scholar
- 213.Khan BV, Parthasarathy SS, Alexander RW, Medford RM. Modified low density lipoprotein and its constituents augment cytokine activated vascular dell adhesion molecule-1 gene expression in human vascular endothelial cells. J Clin Invest. 1995;95:1262.PubMedCrossRefGoogle Scholar
- 214.D’Alessio P, Moutet M, Coudrier E, Darquenne S, Chaudiere J. ICAM-1 and VCAM-1 expression induced by TNF-alpha are inhibited by a glutathione peroxidase mimic. Free Radie Biol Med. 1998;24:979.CrossRefGoogle Scholar
- 215.Amberger A, Maczek C, Jurgens G, Michaelis D, Schert G, Trieb K, Eberl T, Jindal S, Xu Q, Wick G. Co-expression of ICAM-1, VCAM-1 ELAM-1 and Hsp60 in human arterial and venous endothelial cells in response to cytokines and oxidized low-density lipoproteins. Cell Stress & Chap. 1997;2:94.CrossRefGoogle Scholar
- 216.van der Vliet A, Eiserich JP, Halliwell B, Cross CE. Formation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite. J Biol Chem. 1997;272:7617PubMedCrossRefGoogle Scholar
- 217.Eiserich JP, Cross CE, Jones AD, Halliwell B, van der Vliet, A. Formation of nitrating and chlorinating species by reaction of nitrite with hypocholorous acid. J Biol Chem. 1996;271:19199.PubMedCrossRefGoogle Scholar
- 218.Savenkova MI, Meuller DM, Heinecke JW. Tyrosyl radical generated by myeloperoxidase is a physiological catalyst for the initiation of lipid peroxidation in low density lipoprotein. J Biol Chem. 1994;269:20394.PubMedGoogle Scholar
- 219.Hazell LJ, Arnold L, Flowers D, Waeg G, Malle E, Stocker R. Presence of hypochloritemodified proteins in human atherosclerotic lesions. J Clin Invest. 1996;97:1535PubMedCrossRefGoogle Scholar
- 220.Heller R, Münscher-Paulig, F.; Gräbner, R; Till, U. Ascorbic acid potentiates nitric oxide synthesis in endothelial cells. J Biol. Chem 1999;274:8254.PubMedCrossRefGoogle Scholar